Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Intangibles: 2021-2025

Historic Intangibles for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to $90.8 million.

  • Xeris Biopharma Holdings' Intangibles fell 10.67% to $90.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.8 million, marking a year-over-year decrease of 10.67%. This contributed to the annual value of $98.9 million for FY2024, which is 9.88% down from last year.
  • Xeris Biopharma Holdings' Intangibles amounted to $90.8 million in Q3 2025, which was down 2.90% from $93.5 million recorded in Q2 2025.
  • Over the past 5 years, Xeris Biopharma Holdings' Intangibles peaked at $131.4 million during Q4 2021, and registered a low of $90.8 million during Q3 2025.
  • Moreover, its 3-year median value for Intangibles was $104.3 million (2024), whereas its average is $104.3 million.
  • Data for Xeris Biopharma Holdings' Intangibles shows a maximum YoY decreased of 10.67% (in 2025) over the last 5 years.
  • Over the past 5 years, Xeris Biopharma Holdings' Intangibles (Quarterly) stood at $131.4 million in 2021, then decreased by 8.25% to $120.6 million in 2022, then decreased by 8.99% to $109.8 million in 2023, then declined by 9.88% to $98.9 million in 2024, then fell by 10.67% to $90.8 million in 2025.
  • Its Intangibles stands at $90.8 million for Q3 2025, versus $93.5 million for Q2 2025 and $96.2 million for Q1 2025.